FA
HCAT icon

Friess Associates’s Health Catalyst HCAT Stock Holding History

Friess Associates’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-195,873
Closed -$5.12M – 113
2020
Q1 		$5.12M Sell
195,873
-983
-0.5% -$30K 0.51% 59
2019
Q4 		$6.83M Buy
196,856
+113,063
+135% +$3.74M 0.48% 66
2019
Q3 		$2.65M Buy
+83,793
New +$3.3M 0.2% 83

Other funds holding HCAT

NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Friess Associates's HCAT Position: Q2 2020 in Review

Friess Associates sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 195,873 shares — an estimated $5.12M sold.

Friess Associates first reported a position in HCAT in Q3 2019 and held it in 3 quarters. The position peaked at $6.83M in Q4 2019. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • Friess Associates reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
  • Friess Associates sold 195,873 Health Catalyst shares in Q2 2020, an estimated $5.12M.
  • Friess Associates first reported a position in Health Catalyst in Q3 2019 and held it in 3 quarters.
  • Friess Associates's Health Catalyst position peaked at $6.83M in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on Friess Associates's 13F filing for Q2 2020, filed 14 Aug 2020.